BR0308799A - co-glóbulos de dha e alecrim e método de uso - Google Patents

co-glóbulos de dha e alecrim e método de uso

Info

Publication number
BR0308799A
BR0308799A BRPI0308799-9A BR0308799A BR0308799A BR 0308799 A BR0308799 A BR 0308799A BR 0308799 A BR0308799 A BR 0308799A BR 0308799 A BR0308799 A BR 0308799A
Authority
BR
Brazil
Prior art keywords
dha
rosemary
globules
improved blood
cogolbles
Prior art date
Application number
BRPI0308799-9A
Other languages
English (en)
Inventor
John C Lang
Yoav Blatt
Pavael Kazhdan
Rika Pinto
Oleg Safronchik
Original Assignee
Alcon Inc
Biodar Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc, Biodar Ltd filed Critical Alcon Inc
Publication of BR0308799A publication Critical patent/BR0308799A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

"CO-GLóBULOS DE DHA E ALECRIM E MéTODO DE USO". A presente invenção refere-se a proporcionar formulações em glóbulos aperfeiçoados úteis para a inclusão de suplementos dietéticos customizados para melhora e manutenção da nutrição ocular. Em particular, os glóbulos aperfeiçoados compreendem DHA (ácido docosahexaenóico); alecrim e/ou seus componentes; e excipientes.
BRPI0308799-9A 2002-03-28 2003-03-28 co-glóbulos de dha e alecrim e método de uso BR0308799A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36830102P 2002-03-28 2002-03-28
PCT/US2003/009643 WO2003082313A1 (en) 2002-03-28 2003-03-28 Co-beadlet of dha and rosemary and methods of use

Publications (1)

Publication Number Publication Date
BR0308799A true BR0308799A (pt) 2007-01-09

Family

ID=28675471

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0308799-9A BR0308799A (pt) 2002-03-28 2003-03-28 co-glóbulos de dha e alecrim e método de uso

Country Status (10)

Country Link
US (1) US20050106272A1 (pt)
EP (1) EP1487469B1 (pt)
JP (1) JP2005527559A (pt)
AR (1) AR039170A1 (pt)
AT (1) ATE410175T1 (pt)
AU (1) AU2003222111A1 (pt)
BR (1) BR0308799A (pt)
CA (1) CA2479915A1 (pt)
DE (1) DE60323947D1 (pt)
WO (1) WO2003082313A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7239755B1 (en) * 1997-07-30 2007-07-03 Lg Electronics Inc. Method of reducing a blocking artifact when coding moving picture
EP1487418B1 (en) * 2002-03-28 2008-06-18 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
GB0314624D0 (en) * 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20070166354A1 (en) 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
ES2277557B1 (es) * 2005-12-21 2008-07-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
NZ569676A (en) 2005-12-21 2012-03-30 Brudy Technology S L Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
EP1925302A1 (en) 2006-11-24 2008-05-28 DSMIP Assets B.V. Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression
MX2009007701A (es) * 2007-01-19 2009-07-29 Iams Company Composicion y metodo de ingrediente sensible estabilizado.
MX2009007700A (es) * 2007-01-19 2009-07-29 Iams Company Composicion y metodo de ingrediente sensible estabilizado.
WO2008132713A1 (en) * 2007-04-29 2008-11-06 Shemen Industries Ltd. Nourishing oil composition for infants and young children
WO2009016091A1 (en) * 2007-08-01 2009-02-05 Unilever Plc Coated particles
CN101902922B (zh) * 2007-12-21 2013-11-06 巴斯夫欧洲公司 含有脂溶性活性物质的微胶囊
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
US20100159029A1 (en) * 2008-12-23 2010-06-24 Alcon Research, Ltd. Composition and nutritional supplements for improving ocular health and reducing ocular inflammatory response
MX2011007856A (es) 2009-01-30 2011-08-15 Unilever Nv Emulsiones de aceite en agua.
JP5560017B2 (ja) * 2009-10-13 2014-07-23 旭化成ケミカルズ株式会社 脂肪酸、トリグリセリドまたはその混合物を含むマルチコアマイクロカプセルを含有する錠剤およびその製法
CA2774054A1 (en) * 2009-11-06 2011-05-12 Alcon Research, Ltd. Nutritional supplements for relief of dry eye
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
SG10201603856PA (en) 2010-12-31 2016-07-28 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
MY192208A (en) 2010-12-31 2022-08-08 Abbott Lab Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
CA2822495C (en) 2010-12-31 2020-12-22 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
SG191395A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
CN103379908B (zh) 2010-12-31 2020-02-14 雅培制药有限公司 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法
EP3756672A1 (en) 2010-12-31 2020-12-30 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
CA2842672A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN104023560A (zh) 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
JP6375296B2 (ja) * 2013-07-10 2018-08-15 ライオン株式会社 脳機能改善用内服組成物、脳内アミロイドβ蓄積抑制用内服組成物、脳機能改善用食品組成物及び脳内アミロイドβ蓄積抑制用食品組成物
CA2963817A1 (en) * 2014-10-08 2016-04-14 Abbott Laboratories Nutritional compositions comprising an oxidizable component and water-soluble plant extract
WO2017144435A1 (en) * 2016-02-26 2017-08-31 Dsm Ip Assets B.V. Novel coating system (ii)
CN105919946B (zh) * 2016-05-31 2019-03-12 福格森（武汉）生物科技股份有限公司 一种dha微丸的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
CH627449A5 (de) * 1977-03-25 1982-01-15 Hoffmann La Roche Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt.
IE52725B1 (en) * 1981-04-13 1988-02-03 Kuraray Co Method for production of formed food product of microfibrillar milk protein
AU552068B2 (en) * 1981-09-21 1986-05-22 Asama Chemical Co. Ltd. Preservation of edible oils
US4670247A (en) * 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
DK88692D0 (da) * 1992-07-06 1992-07-06 Danochemo As Fremgangsmaade til fremstilling af mikrokapsler
US6582721B1 (en) * 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US7097868B2 (en) * 2001-08-23 2006-08-29 Bio-Dar Ltd. Stable coated microcapsules
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
DE20205184U1 (de) * 2002-03-27 2002-12-19 Bartz Volker Blutfettsenker zur oralen Einnahme
EP1487418B1 (en) * 2002-03-28 2008-06-18 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use

Also Published As

Publication number Publication date
JP2005527559A (ja) 2005-09-15
AU2003222111A1 (en) 2003-10-13
AR039170A1 (es) 2005-02-09
DE60323947D1 (de) 2008-11-20
ATE410175T1 (de) 2008-10-15
CA2479915A1 (en) 2003-10-09
EP1487469A4 (en) 2007-05-09
EP1487469B1 (en) 2008-10-08
WO2003082313A1 (en) 2003-10-09
EP1487469A1 (en) 2004-12-22
US20050106272A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
BR0211814A (pt) Formulação contendo (liso-)fosfatidilserina para a prevenção e tratamento de estados de tensão em animais de sangue quente
CA2578881A1 (en) Vitamin d compositions and method of administration to a human being
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
BR0307935A (pt) Sais de trans carotenóide bipolares e seus usos
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
BR0314666A (pt) Composição nutricional ou terapêutica utilizável para o tratamento de mamìferos para aumentar a atividade imune e método de tratar um mamìfero para aumentar a concentração de glutationa no tecido no referido mamìfero
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
HUP0304077A2 (hu) A bőr öregedése elleni gyógyászati és kozmetikai készítmények
DK0942741T3 (da) Lektinpræparater og anvendelser deraf
BRPI0417884A (pt) composições compreendendo vitaminas e/ou derivados das mesmas, estabilizados com extrato de olea europea e/ou polìmeros de ioneno
SI1635776T1 (sl) Sistemi proteinov za prenos lipidov in njihova kozmetična dermatološka uporaba
KR20110015171A (ko) 연산호류 추출물 및 그것의 용도
CA2620313A1 (en) Nutritional method for elderly people
BR0312318A (pt) Compostos, uso de um ou mais compostos, composição farmacêutica, composição cosmética e usos cosméticos
TR200300401A2 (tr) Kandaki yağ azaltıcı, ağızdan alınan müstahzarat
DK1409449T3 (da) Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse
ATE171375T1 (de) Pharmazeutische zusammensetzung, die als hilfsmittelbehandlung von seborrhoid-dermatitis, auch bei hiv-patienten, verwendbar ist
ATE110274T1 (de) Mittel zur verbesserung spezifischer eigenschaften des blutes.
BRPI0409790A (pt) 7-azaindóis e seu uso como terapêuticos
US20140107223A1 (en) Topical ubiquinol supplement skin care compositions
AU2003290031A1 (en) Method of improvement of blood circulation
Tavano et al. Food proteins as a tool in human longevity: a mini-review
KR20180056915A (ko) 천연 식물 추출물을 함유하는 선블럭 또는 쿨크림용 화장품 조성물

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/202 (2006.01), A23L 33/105 (2016.01), A23L